Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Janssen
Janssen
Gene therapy startup Passage Bio nabs Janssen neuro lead as CMO
Fierce Biotech
Mon, 09/23/19 - 10:43 am
gene therapy
Passage Bio
Janssen
Half-Off Sale! Five Major Drugmakers Reveal Vast Gross-to-Net Price Gaps—and Why Rebate Reform Is Still Needed
Drug Channels
Tue, 09/17/19 - 03:35 pm
Eli Lilly
Janssen
Merck
Novartis
Sanofi
drug pricing
Janssen’s MS pill outshines Sanofi’s Aubagio in phase 3 trial
Pharmaforum
Thu, 09/12/19 - 10:28 am
JNJ
Janssen
ponesimod
Sanofi
Aubagio
relapsing multiple sclerosis
J&J gets Stelara okay in Europe for ulcerative colitis
Pharmaforum
Fri, 09/6/19 - 08:35 pm
JNJ
Stelara
Janssen
Europe
Companies file suit in Canada challenging new rules to lower drug prices
Yahoo/Reuters
Sun, 08/25/19 - 05:10 pm
drug pricing
Canada
Janssen
Merck
Bayer
Servier
Boehringer Ingelheim
Janssen gets EC approval for two new indications of Imbruvica
Pharmaceutical Business Review
Wed, 08/14/19 - 10:17 am
JNJ
Janssen
Europe
Imbruvica
Waldenström’s macroglobulinemia
chronic lymphocytic leukemia
Janssen returns rights for experimental cancer immunotherapy to Alligator Bioscience, sending shares spiraling by 40%
Pharmaceutical Business Review
Fri, 08/2/19 - 11:48 pm
Janssen
Alligator Biosciences
CD40
cancer immunotherapy
Janssen’s Ponesimod Finds Success in Head-to-Head Multiple Sclerosis Trial
BioSpace
Fri, 07/26/19 - 10:59 am
Janssen
JNJ
ponesimod
Sanofi
Aubagio
relapsing multiple sclerosis
FDA quickly approves J&J’s Darzalex in multiple myeloma
Pharmaforum
Fri, 06/28/19 - 12:32 pm
JNJ
Janssen
FDA
Darzalex
Multiple Myeloma
Time to fix pharma’s outdated business model
Pharmaforum
Sat, 06/22/19 - 12:33 pm
pharma industry
payers
patients
Janssen
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Pharmaceutical Business Review
Tue, 06/18/19 - 11:38 pm
JNJ
Janssen
Tremfya
clinical trials
psoriatic arthritis
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
BioSpace
Fri, 06/14/19 - 06:23 pm
JNJ
Janssen
clinical trials
Tremfya
psoriatic arthritis
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
KHN
Tue, 06/11/19 - 11:41 pm
FDA
Janssen
Spravato
esketamine
major depressive disorder
Janssen Hopes to Improve Communication with Clinical Trial Patients Through New Program
BioSpace
Mon, 06/10/19 - 06:05 pm
Janssen
clinical trials
patients
Janssen inks nference AI research pact
Fierce Biotech
Mon, 06/10/19 - 09:47 am
JNJ
Janssen
R&D
artificial intelligence
nference
J&J passes key milestone in HIV vaccine trial
Pharmaforum
Thu, 05/30/19 - 09:40 am
JNJ
Janssen
clinical trials
vaccines
HIV
Imbokodo
Study Finds Ketamine Nasal Spray Effective For Treating Depression: What You Should Know
Forbes
Thu, 05/23/19 - 10:45 pm
depression
ketamine
esketamine
Spravato
JNJ
Janssen
Most people pay less than $5 per month for the drug. But some pay $11,002
Stat
Wed, 04/17/19 - 09:45 am
JNJ
Janssen
Stelara
drug pricing
J&J's Balversa gets accelerated approval for bladder cancer
BioCentury
Fri, 04/12/19 - 11:40 pm
JNJ
Janssen
Balversa
bladder cancer
FDA
ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
Pharmaceutical Business Review
Thu, 04/4/19 - 11:58 am
ViiV Healthcare
Dolutegravir
rilpivirine
JNJ
Janssen
HIV
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »